# Vimta Labs Limited – FDA 483, Nov 7, 2025

Source: https://www.keypedia.com/records/483/vimta-labs-limited/d41880a2-378e-40af-a20b-daeca02a87f4

> FDA 483 for Vimta Labs Limited on November 07, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Vimta Labs Limited
- Inspection Date: 2025-11-07
- Product Type: drugs
- Office Name: Office of Inspections and Investigations
- Summary: During an inspection of Vimta Labs, Ltd., a bioanalytical facility in Shameerpet, Hyderabad, FDA investigators observed a deficiency in method validation documentation. A robustness experiment, which failed acceptance criteria, was not included in a PSD method validation report. This indicates a potential issue with data integrity and proper reporting of validation studies.

## Related Documents

- [483 - 2026-09-03](https://www.keypedia.com/records/483/vimta-labs-limited/0e95d46f-2eed-4147-945a-a53d877b6e14) — date: September 3, 2026
- [483 - 2023-03-17](https://www.keypedia.com/records/483/vimta-labs-limited/263c464e-744f-4b50-a0ab-f6e95142ada2) — date: March 17, 2023
- [483 - 2019-12-18](https://www.keypedia.com/records/483/vimta-labs-limited/75e60c85-7312-49b7-a243-4724806c6209) — date: December 18, 2019
- [483 - 2018-10-26](https://www.keypedia.com/records/483/vimta-labs-limited/fa32f218-e2dd-43cb-b01d-f6f051fec941) — date: October 26, 2018

## Related Officers

- [Sylvestre K. Dossou](https://www.keypedia.com/people/sylvestre-k-dossou/962f9277-7643-4f66-add9-1c3553fa1c14)

Company: https://www.keypedia.com/companies/vimta-labs-limited/74303e4b-f6dc-4ce6-8216-62d716ea8046

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8